NCT02950168View on ClinicalTrials.gov

Edoxaban Management in Diagnostic and Therapeutic Procedures

CompletedOBSERVATIONAL

Enrollment

1,197

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

July 26, 2018

Study Completion Date

July 26, 2018

Conditions

Atrial FibrillationVenous Thromboembolism

Interventions

PROCEDURE

Edoxaban

Edoxaban according to Summary of Product Characteristic (SMPC)

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY